Court of Appeal Rules in Favour of Competition and Markets Authority in Phenytoin Drug Case
The Court of Appeal has ruled that a specialist tribunal erred in overturning a previous decision by the Competition and Markets Authority regarding its investigation into the epilepsy drug phenytoin. The judgment clarifies the regulator’s authority in examining potential anti-competitive practices in the pharmaceutical sector.